We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Fundamental aspects
-
1. Inflammation and tissue homeostasis
- Prof. Herman Waldmann
-
2. Introduction to the immune system
- Prof. Herman Waldmann
-
3. Hematopoiesis: the making of an immune system
- Prof. Paul J. Fairchild
-
4. Inflammation: purposes, mechanisms and development
- Prof. Pietro Ghezzi
-
5. Phagocytosis
- Dr. Eileen Uribe-Querol
-
6. Regulated cell death mechanisms and their crosstalk with the immune system 1
- Dr. Luis Alberto Baena-Lopez
-
7. Regulated cell death mechanisms and their crosstalk with the immune system 2
- Dr. Luis Alberto Baena-Lopez
- Innate immunity
-
11. Cells of the innate immune system
- Prof. Kevin Maloy
-
12. Microbial recognition and the immune response
- Dr. Dana Philpott
-
13. Toll-like receptor signalling during infection and inflammation
- Prof. Luke O'Neill
- Intercellular mediators
-
14. Chemokines
- Dr. James E. Pease
-
15. Cytokines
- Prof. Iain McInnes
-
16. IL-1 family cytokines as the canonical DAMPs of the immune system
- Prof. Seamus Martin
-
17. Glycans at the frontiers of inflammation, autoimmunity and cancer
- Prof. Salomé S. Pinho
-
18. Glycoimmunology
- Prof. Paula Videira
- Adaptive immunity B cells
-
21. Antigen recognition in the immune system
- Prof. Herman Waldmann
-
22. B cell biology
- Prof. Richard Cornall
-
23. Antibody structure and function: antibody structure
- Dr. Mike Clark
-
24. Antibody structure and function: antibody function
- Dr. Mike Clark
-
25. Antibody genes and diversity
- Dr. Mike Clark
-
26. In vivo antibody discovery and hybridoma technology
- Prof. Dr. Katja Hanack
-
27. Antibody engineering: beginnings to bispecifics and beyond
- Dr. Ian Wilkinson
-
29. The immunobiology of Fc receptors
- Prof. Mark Cragg
-
30. Immunoreceptors
- Prof. Anton van der Merwe
-
31. Affinity, avidity and kinetics in immune recognition
- Prof. Anton van der Merwe
- Adaptive immunity T cells
-
32. The thymus and T cell development: a primer
- Prof. Georg Holländer
-
33. Lineage decisions in the thymus: T cell lineage commitment
- Prof. Bruno Silva-Santos
-
34. Lineage decisions in the thymus: αβ and γδ T cell lineages
- Prof. Bruno Silva-Santos
-
35. CD4 T cell subsets
- Dr. Brigitta Stockinger
-
36. Cytotoxic T lymphocytes
- Prof. Gillian M. Griffiths
-
37. Gamma delta T-cells
- Prof. Bruno Silva-Santos
-
38. Tfh and Tfr cells
- Prof. Luis Graca
-
39. Tissue resident memory T cells (TRM)
- Dr. Marc Veldhoen
-
40. Mathematical modeling in immunology
- Prof. Ruy M. Ribeiro
- The importance of the MHC in immunity
-
41. The MHC and MHC molecules 1
- Prof. Jim Kaufman
-
42. The MHC and MHC molecules 2
- Prof. Jim Kaufman
-
43. Natural killer cells
- Dr. Philippa Kennedy
-
44. Human NK cells
- Prof. Lorenzo Moretta
-
46. NK cells in viral immunity
- Prof. Lewis Lanier
- Lymphocyte activation
-
47. Signal transduction by leukocyte receptors
- Dr. Omer Dushek
-
48. Immunological memory 1
- Prof. David Gray
-
49. Immunological memory 2
- Prof. David Gray
-
50. Studying immune responses “one cell at a time”
- Dr. Mir-Farzin Mashreghi
- Major cellular partners in immunity
-
51. The mononuclear phagocyte system - tissue resident macrophages: distribution and functions
- Prof. Emeritus Siamon Gordon
-
52. The mononuclear phagocyte system: tissue resident macrophages - activation and regulation
- Prof. Emeritus Siamon Gordon
-
53. Dendritic cells: professional antigen presenting cells
- Prof. Paul J. Fairchild
-
54. Mucosal immunology
- Prof. Daniel Mucida
- Immunological tolerance and regulation
-
55. Self-tolerance
- Prof. Herman Waldmann
-
56. Tolerance and autoimmunity
- Prof. Emerita Anne Cooke
-
57. The balance between intestinal immune homeostasis and inflammation
- Prof. Dr. Janneke Samsom
- Translational immunology - immune deficiency
-
58. Primary immunodeficiency disorders
- Dr. Smita Y. Patel
-
59. Changes in innate and adaptive immunity during human ageing 1
- Dr. Roel De Maeyer
-
60. Changes in innate and adaptive immunity during human ageing 2
- Dr. Roel De Maeyer
-
61. The aging immune system
- Prof. Ana Caetano
- Translational immunology - protection against pathogenic microbes
-
62. Immune responses to viruses
- Prof. Paul Klenerman
-
63. HIV and the immune system
- Prof. Quentin Sattentau
-
64. COVID-19: the anti-viral immune response
- Prof. Danny Altmann
-
65. Bacterial immune evasion
- Prof. Christoph Tang
-
66. The immunology underlying tuberculosis
- Prof. Thomas R. Hawn
-
67. Innate immunity to fungi
- Prof. Gordon D. Brown
-
68. Parasite immunity: introduction and Plasmodium
- Dr. Catarina Gadelha
-
69. Parasite immunity: Leishmania and Schistosoma
- Dr. Catarina Gadelha
-
70. Vaccination
- Dr. Anita Milicic
-
71. The history of vaccines 1
- Prof. Emeritus Anthony R. Rees
-
72. The history of vaccines 2
- Prof. Emeritus Anthony R. Rees
-
73. The history of vaccines 3
- Prof. Emeritus Anthony R. Rees
-
74. The science of vaccine adjuvants
- Dr. Derek O'Hagan
- Translational immunology - hypersensitivity, autoimmune disease and their management
-
75. Hypersensitivity diseases: type 1 hypersensitivity
- Prof. Herman Waldmann
-
76. Innate lymphoid cells in allergy
- Prof. Emeritus Shigeo Koyasu
-
77. Hypersensitivity diseases: type II-IV hypersensitivity
- Prof. Sara Marshall
-
78. Immune memory underlying lifelong peanut allergy
- Dr. Kelly Bruton
-
79. Memory B cells in allergy: B cell activation and response
- Dr. Kelly Bruton
-
80. Memory B cells in allergy: ontogeny, phenotype and plasticity
- Dr. Kelly Bruton
-
81. B cells at the crossroads of autoimmune diseases
- Dr. Xiang Lin
-
82. Interleukin-17: from clone to clinic
- Prof. Leonie Taams
-
83. Autoimmunity and type 1 diabetes
- Prof. Emerita Anne Cooke
-
84. What is new in type 1 diabetes?
- Prof. Åke Lernmark
-
85. Antibodies to control or prevent type 1 diabetes
- Dr. Robert Hilbrands
-
86. Monoclonal antibodies in haemato-oncology
- Prof. Mark Cragg
-
87. Therapeutic antibodies
- Dr. Geoffrey Hale
-
88. Endothelial cells: regulators of autoimmune-neuroinflammation
- Dr. Laure Garnier
-
89. Neuroimmunometabolism
- Prof. Ana Domingos
-
90. The immunology of multiple sclerosis
- Dr. Joanne Jones
-
91. Immunology of the peripheral nervous system: the inflammatory neuropathies
- Dr. Simon Rinaldi
-
92. Ocular immunology: an overview of immune mechanisms operating in the eye
- Dr. Eleftherios Agorogiannis
-
93. Understanding myasthenia gravis and advances in its management
- Prof. Henry J. Kaminski
-
94. The immunology underlying rheumatic diseases
- Dr. Hussein Al-Mossawi
-
96. Complement and lupus
- Prof. Marina Botto
-
97. Immune mechanisms in liver diseases
- Prof. Paul Klenerman
- Translational immunology - transplantation immunology
-
98. Principles of transplantation: overview of the immune response
- Prof. Emerita Kathryn Wood
-
99. Factors influencing outcomes in clinical transplantation 1
- Prof. Emerita Kathryn Wood
-
100. Factors influencing outcomes in clinical transplantation 2
- Prof. Emerita Kathryn Wood
- Translational immunology - cancer immunology
-
101. Cancer immunology
- Prof. Tim Elliott
-
102. Cancer immunotherapy
- Prof. Tim Elliott
-
103. Myeloid-derived suppressor cells in cancer
- Prof. Dmitry Gabrilovich
-
104. IL-2 in the immunotherapy of autoimmunity and cancer
- Prof. Thomas Malek
-
105. Latest advances in the development of CAR & TCR T-cell treatments for solid tumours
- Dr. Else Marit Inderberg
Printable Handouts
Navigable Slide Index
- Introduction
- Outline of talk (1)
- Chemotactic cytokines – chemokines (1)
- Chemotactic cytokines – chemokines (2)
- Chemotaxis
- Chemokine nomenclature
- Chemokine receptor signalling (1)
- Chemokine receptor signalling (2)
- Different leukocytes express different repertoires of chemokine receptors
- The chemokine family
- Entry of leukocytes into tissues
- Leukocytes trafficking from the circulation to the tissues
- Chemokines and glycosaminoglycans (GAGs)
- Chemokines with mucin stalks
- Chemokines have other vital roles
- Atypical chemokine receptors (1)
- Atypical chemokine receptors (2)
- Outline of talk (2)
- Microbial corruption of the chemokine system (1)
- ‘Flattery that turns to battery’
- Microbial corruption of the chemokine system (2)
- Microbial corruption of the chemokine system (3)
- A 32 base pair deletion in CCR5 confers resistance to HIV-1 infection
- Subversion – SpyCEP & necrotising fasciitis
- Streptococcus pyogenes
- SpyCEP cleaves the C-terminal helix of CXCL8, impairing its chemotactic activity
- Outline of talk (3)
- Chemokines as a double edged sword
- Chemokine receptors as targets in the treatment of asthma
- CCR3 – the eotaxin receptor
- How does UCB35625 antagonise CCR3?
- UCB35625 inhibits the chemotactic response to CCL11 but not ligand binding
- How does UCB35625 work?
- Modelling the inhibition of CCL11:CCR3 by UCB35625
- Chemokine receptor crystal structures
- Models for chemokine receptor activation and antagonism
- Biased agonism at chemokine receptors: obstacles or opportunities for drug discovery?
- The hunt for chemokine receptor antagonists
- Are chemokine receptors good drug targets?
- CCR5 as a drug target
- WHIM Syndrome
- Why have antagonists failed in the clinic?
- Promiscuous GPCR antagonists
- Characterisation of broad spectrum chemokine receptor antagonists
- CCR3 is a target for age-related macular degeneration
- Acknowledgements
Topics Covered
- Chemokine classification
- Chemokine function
- Chemokine signaling
- Microbial corruption of the chemokine system
- Therapeutic blockade of chemokine receptors
Links
Series:
Categories:
Therapeutic Areas:
External Links
Talk Citation
Pease, J.E. (2022, March 9). Chemokines [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved February 5, 2025, from https://doi.org/10.69645/NTNU3339.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. James E. Pease has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Immunology
Transcript
Please wait while the transcript is being prepared...
0:00
Welcome to this
talk on chemokines.
My name is Dr. James Pease.
I'm a reader in
leukocyte biology
at the National Heart & Lung Institute at
Imperial College London, United Kingdom.
0:15
The outline of this talk on
chemokines is in three parts.
In the first part, I'm going to
talk about chemokines themselves.
I'm going to introduce their classification,
their function and their signalling.
In the second part,
I'll talk about how microbes have corrupted
the chemokines system for their own purposes.
In the third and final part,
I'll talk about work on the therapeutic blockade
of chemokine receptors in various diseases.
Let's start off by introducing chemokines and talking
about their classification, function and signalling.
0:51
The term chemokine
is a portmanteau.
It comes from the phrase
chemotactic cytokines
and defines cytokines that
drive the chemotaxis of cells.
That's principally
leukocyte migration.
Chemokines are small
soluble proteins,
typically around 8-10
kDa in molecular weight
and they adopt a
tertiary structure,
as shown here in this slide.
It's notable for the presence
of a 'greek-key' motif,
which is three anti-parallel
β pleated sheets
and the C-terminal α helix.
The structure of a chemokine is
underpinned by two disulfide bonds,
and they're typically
secreted as mature peptides
following the removal or excision
of a short signal peptide.
1:37
The family of 40 or so
chemokines in the human
can be conveniently subdivided
into four major classes,
and that's based on their arrangement
of N-terminal cysteine residues.
The majority of chemokines
fall into the families
known as the CC and
the CXC families.
CC chemokines concern an N-terminus
with two adjacent cysteine residues,
whereas the CXC chemokines have a single amino
acid interspersed between the cysteines.
There are also a couple of
minor chemokine families.
The CX_3C family contains three amino
acids between these N-terminal cysteines.
Whilst the C chemokines have a single
cysteine residue in their N-terminus.
Chemokines are predominately
quite basic molecules,
and they have several conserved
lysine and arginine residues,
notably in the C-terminus.
The primary function of chemokines
is shown on this slide here.
They drive the
chemotaxis of cells.
That can be defined as the directional migration
of a cell towards a chemical stimulus.